| Literature DB >> 34772976 |
Simon Kornvig1, Maria Wielsøe1, Manhai Long1, Eva Cecilie Bonefeld-Jørgensen2,3.
Abstract
High levels of persistent organic pollutants (POPs) and heavy metals are found in Arctic populations. POP and heavy metals are linked to impaired cognitive development. This study examined associations between prenatal POP and metals exposure and problematic child behavior using the Strength and Difficulties Questionnaire (SDQ). POPs and metals were measured in 102 pregnant Greenlandic women. During follow-up at 3-5 years, parents answered an assisted questionnaire including children's SDQ scores. Associations were analyzed using linear and logistic regression analyses and adjusted for maternal plasma cotinine, educational level and age at delivery. In the adjusted analyses, the medium tertile of hexachlorobenzene (β = 3.06, p = 0.010), β-hexachlorocyclohexane (β = 3.58, p = 0.004) and trans-nonachlor (β = 2.06, p = 0.082) were positively associated with SDQ scores. The continuous cis-nonachlor (OR = 1.09, p = 0.079), dichloro-diphenyl-dichloroethylene (OR = 1.01, p = 0.077), trans-nonachlor (OR = 1.01, p = 0.091), and sum Organochlorine-Pesticides (OR = 1.00, p = 0.094) were positively associated with abnormal SDQ score and the continuous mirex (OR = 1.28, p = 0.096), oxychlordane (OR = 1.04, p = 0.066), and trans-nonachlor (OR = 1.02, p = 0.071) with abnormal hyperactivity score. We found no consistent evidence of associations between polychlorinated biphenyls, perfluoroalkylated substances and heavy metals and problematic behavior. Prenatal organochlorine pesticide exposure associated significantly with problematic behavior in 3-5 year old children.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34772976 PMCID: PMC8589846 DOI: 10.1038/s41598-021-01580-0
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Flowchart showing the process of inclusion and exclusion of mother–child pairs for the ACCEPT follow-up study.
Maternal characteristics: pregnant Greenlandic women in the ACCEPT cohort 2013–2015.
| All | Nuuk | Sisimiut and Ilulissat | ||
|---|---|---|---|---|
| 102 (100) | 69 (67.7) | 33 (32.3) | 0.559 τ | |
| n | 102 | 69 | 33 | |
| Mean ± SD | 29.3 ± 4.56 | 29.4 ± 4.14 | 28.9 ± 5.38 | |
| Median (min–max) | 29.2 (20.1–41.5) | 29.2 (21.8–38.2) | 28.0 (20.1–41.5) | |
| Missing, n (%) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| n | 100 | 67 | 33 | 0.196 τ |
| Mean ± SD | 25.6 ± 4.75 | 25.1 ± 4.41 | 26.4 ± 5.35 | |
| Median (min–max) | 24.1 (18.7–43.1) | 24.0 (19.1–40.2) | 24.7 (18.7–43.1) | |
| Missing, n (%) | 2 (2.0) | 2 (2.9) | 0 (0.0) | |
| n | 97 | 67 | 30 | |
| Mean ± SD | 0.96 ± 1.08 | 0.81 ± 1.00 | 1.30 ± 1.18 | |
| Median (min–max) | 1 (0–4) | 0 (0–4) | 1 (0–4) | |
| 0, n (%) | 43 (44.3) | 35 (52.2) | 8 (26.7) | |
| 1–2, n (%) | 45 (46.4) | 28 (41.8) | 17 (56.7) | |
| 3 or more, n (%) | 9 (9.3) | 4 (6.0) | 5 (16.7) | |
| Missing, n (%) | 5 (4.9) | 2 (2.9) | 3 (9.1) | |
| n | 102 | 69 | 33 | 0.118 χ |
| No, n (%) | 81 (79.4) | 58 (84.1) | 23 (69.7) | |
| Yes, (%) | 21 (20.6) | 11 (15.9) | 10 (30.3) | |
| Missing, n (%) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| n | 102 | 69 | 33 | |
| Mean ± SD | 25.9 ± 61.3 | 17.8 ± 47.2 | 42.9 ± 81.8 | 0.115 τ |
| Median (min–max) | 0.50 (0.50–298) | 0.50 (0.50–254) | 0.50 (0.50–298) | |
| Mean ± SD | 1.60 ± 20.5 | 1.71 ± 5.1 | 1.32 ± 2.8 | 0.729 τ |
| Median (min–max) | 0.50 (0.50–31.7) | 0.50 (0.50–31.7) | 0.50 (0.50–12.1) | |
| Mean ± SD | 119.5 ± 85.5 | 102.3 ± 75.3 | 138 ± 95.9 | 0.417 τ |
| Median (min–max) | 97.8 (7.0–298) | 94.2 (7.0–254) | 129 (0.50–298) | |
| Missing, n (%) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| n | 101 | 69 | 32 | |
| Primary school, n (%) | 21 (20.8) | 6 (8.7) | 15 (46.9) | |
| Secondary School, n (%) | 13 (12.9) | 9 (13.0) | 4 (12.5) | |
| Technical college, n (%) | 38 (37.6) | 31 (44.9) | 7 (21.9) | |
| University, n (%) | 29 (28.7) | 23 (33.3) | 6 (18.8) | |
| Missing, n (%) | 1 (1.0) | 0 (0.0) | 1 (3.0) | |
| n | 93 | 66 | 27 | 0.463 χ |
| < 1 time a month | 51 (54.8) | 36 (54.5) | 15 (55.6) | |
| 1 time a month | 19 (20.4) | 13 (19.7) | 6 (22.2) | |
| 2–3 times a month | 17 (18.3) | 11 (16.7) | 6 (22.2) | |
| > 1 time a week | 6 (6.5) | 6 (9.1) | 0 (0.0) | |
| Missing, n (%) | 9 (8.8) | 3 (4.3) | 6 (18.2) | |
| n | 43 | 30 | 13 | N/A |
| < 1 time a month | 43 (100.0) | 30 (100.0) | 13 (100.0) | |
| 1 time a month | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| 2–3 times a month | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| > 1 time a week | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| Missing, n (%) | 59 (57.8) | 39 (56.5) | 20 (60.6) | |
| n | 101 | 68 | 33 | 0.684 τ |
| Mean ± SD | 0.27 ± 0.11 | 0.27 ± 0.10 | 0.28 ± 0.13 | |
| Median (min–max) | 0.24 (0.10–0.73) | 0.24 (0.11–0.57) | 0.26 (0.10–0.73) | |
| Missing, n (%) | 1 (1.0) | 1 (1.4) | 0 (0.0) | |
| n | 102 | 69 | 33 | 0.803 |
| Mean ± SD | 6.47 ± 1.04 | 6.51 ± 1.11 | 6.44 ± 1.01 | |
| Median (min–max) | 6.50 (4.30–8.90) | 6.40 (4.40–8.90) | 6.50 (4.30–8.90) | |
| Missing, n (%) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
N total number of participants, n number of participants with information on the variable, τ: p-Value was calculated with student T-test on ln-transformed data, χ: p-Value was calculated with Chi-square test, Bold text and * = Significant (p ≤ 0.050), N/A: Test not applicable.
Child characteristics: Greenlandic children born 2014–2016 in the ACCEPT birth cohort.
| All | Nuuk | Sisimiut and Ilulissat | ||
|---|---|---|---|---|
| N (%) | 102 (100) | 69 (67.7) | 33 (32.3) | |
| Male, n (%) | 55 (53.9) | 40 (58.0) | 15 (45.5) | 0.290 χ |
| Female, n (%) | 47 (46.1) | 29 (42.0) | 18 (54.5) | |
| Missing, n (%) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| n | 102 | 69 | 33 | |
| Mean ± SD | 39.5 ± 1.45 | 39.7 ± 1.43 | 39.1 ± 1.42 | |
| Median (min–max) | 40 (35–42) | 40 (37–42) | 39 (35–41) | |
| Missing, n (%) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| Mean ± SD | 3671 ± 518 | 3743 ± 501 | 3521 ± 529 | |
| Median (min–max) | 3675 (2220–4920) | 3712 (2640–4920) | 3490 (2220–4505) | |
| Missing, n (%) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| Mean ± SD | 51.6 ± 2.27 | 51.9 ± 2.31 | 51.0 ± 2.08 | |
| Median (min–max) | 52 (46–57) | 52 (46–57) | 51 (46–55) | |
| Missing, n (%) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| n | 101 | 69 | 32 | |
| Mean ± SD | 35.0 ± 1.51 | 35.1 ± 1.46 | 34.5 ± 1.57 | |
| Median (min–max) | 35.0 (31.0–38.5) | 35.0 (32.0–38.5) | 34.5 (31–38) | |
| Missing, n (%) | 1 (1.0) | 0 (0.0) | 1 (3.0) | |
| n | 101 | 68 | 33 | |
| None, n (%) | 4 (4.0) | 2 (2.9) | 2 (6.1) | |
| < 6 months, n (%) | 17 (16.8) | 8 (11.8) | 9 (27.3) | |
| 6–12 months, n (%) | 31 (30.7) | 20 (29.4) | 11 (33.3) | |
| > 1 year, n (%) | 49 (48.5) | 38 (55.9) | 11 (33.3) | |
| Missing, n (%) | 1 (1.0) | 1 (1.4) | 0 (0.0) | |
| n | 102 | 69 | 33 | |
| Mean ± SD | 53.7 ± 6.98 | 52.8 ± 7.20 | 55.4 ± 6.24 | |
| Median (min–max) | 54 (40–66) | 52 (40–66) | 55 (45–65) | |
| Missing, n (%) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| n | 95 | 65 | 30 | 0.884 τ |
| Mean ± SD | 10.2 ± 5.18 | 10.2 ± 4.78 | 10.3 ± 6.05 | |
| Median (min–max) | 9 (0–25) | 9 (3–25) | 9 (0–22) | |
| Normal, n (%) | 74 (77.9) | 53 (81.5) | 21 (70.0) | 0.247 χ |
| Boys/Girls, n (%) | 38 (74.5)/36 (81.8) | 28 (75.7)/25 (86.3) | 10 (71.4)/11 (68.8) | |
| Borderline, n (%) | 10 (10.5) | 7 (10.8) | 3 (10.0) | |
| Boys/Girls, n (%) | 6 (11.8)/4 (9.1) | 5 (12.5)/2 (7.1) | 1 (7.1)/2 (12.5) | |
| Abnormal, n (%) | 11 (11.6) | 5 (7.7) | 6 (20.0) | |
| Boys/Girls, n (%) | 7 (13.7)/4 (9.1) | 4 (10.8)/1 (3.6) | 3 (21.4)/3 (18.8) | |
| Missing, n (%) | 7 (6.9) | 4 (5.8) | 3 (9.1) | |
| N | 101 | 69 | 32 | 0.654 τ |
| Mean ± SD | 3.36 ± 1.89 | 3.57 ± 1.79 | 2.91 ± 2.05 | |
| Median (min–max) | 3 (0–7) | 4 (0–7) | 3 (0–7) | |
| Normal, n (%) | 88 (87.1) | 60 (87.0) | 28 (87.5) | 0.899 χ |
| Boys/Girls, n (%) | 46 (83.6)/42 (91.3) | 33 (82.5)/27 (93.1) | 13 (86.7)/15 (88.2) | |
| Borderline, n (%) | 8 (7.9) | 5 (7.2) | 3 (9.4) | |
| Boys/Girls, n (%) | 5 (9.1)/3 (6.5) | 3 (7.5)/2 (6.9) | 2 (13.3)/1 (5.9) | |
| Abnormal, n (%) | 5 (5.0) | 4 (5.8) | 1 (3.1) | |
| Boys/Girls, n (%) | 4 (7.3)/1 (2.2) | 4 (10.0)/0 (0.0) | 0 (0.0)/1 (5.9) | |
| Missing, n (%) | 1 (1.0) | 0 (0.0) | 1 (3.0) | |
N total number of participants, n number of participants with information on the variable, τ: p-Value was calculated with T-test on ln-transformed data, χ: p-Value was calculated with Chi-square test for locations, Bold text and * = Significant (p ≤ 0.050), Bold text and ** = Borderline significant (p ≤ 0.100), Missing % was calculated on the basis of all responders and non-responders.
Concentrations of POPs and metals: Greenlandic pregnant women in the ACCEPT cohort 2013–2015.
| % over DL | All (N = 102) | Nuuk (N = 69) | Sisimiut and Ilulissat (N = 33) | |||||
|---|---|---|---|---|---|---|---|---|
| GM ± GSD | Median (min–max) | GM ± GSD | Median (min–max) | GM ± GSD | Median (min–max) | |||
| PCB118 | 98 | 7.91 ± 2.15 | 8.65 (0.50–47.0) | 6.97 ± 2.19 | 7.30 (0.50–32.0) | 10.3 ± 1.95 | 9.90 (2.30–47.0) | |
| PCB138 | 100 | 22.3 ± 2.04 | 23.0 (2.40–110) | 19.8 ± 2.06 | 20.0 (2.40–93.0) | 28.7 ± 1.87 | 29.0 (7.70–110) | |
| PCB153 | 100 | 46.7 ± 2.09 | 48.0 (5.10–250) | 40.9 ± 2.09 | 42.0 (5.10–220) | 61.8 ± 1.96 | 60.0 (16.0–250) | |
| PCB156 | 75.5 | 2.55 ± 2.34 | 2.70 (0.50–16.0) | 2.40 ± 2.35 | 2.70 (0.50–16.0) | 2.89 ± 2.32 | 2.80 (0.50–13.0) | 0.308 |
| PCB170 | 99 | 7.72 ± 2.04 | 7.85 (1.30–39.0) | 7.10 ± 2.06 | 7.40 (1.30–39.0) | 9.21 ± 1.95 | 8.40 (2.80–35.0) | |
| PCB180 | 100 | 23.0 ± 2.08 | 22.5 (3.80–120) | 20.7 ± 2.08 | 22.0 (3.80–120) | 28.5 ± 2.02 | 27.0 (8.70–110) | |
| PCB183 | 76.5 | 2.48 ± 2.22 | 2.75 (0.50–12.0) | 2.16 ± 2.23 | 2.30 (0.50–11.0) | 3.33 ± 2.04 | 3.60 (0.50–12.0) | |
| PCB187 | 97 | 10.6 ± 2.05 | 11.0 (1.60–48.0) | 9.34 ± 2.03 | 9.00 (1.60–48.0) | 13.8 ± 1.95 | 12.0 (3.60–44.0) | |
| PCB99 | 66.7 | 6.38 ± 2.24 | 7.00 (1.50–39.0) | 5.54 ± 2.22 | 6.00 (1.50–32.0) | 8.57 ± 2.14 | 10.0 (2.00–39.0) | |
| 159 ± 1.88 | 167 (37.7–675) | 142 ± 1.87 | 144 (37.7–648) | 200 ± 1.79 | 187 (66.6–675) | |||
| cis-Nonachlor | 97 | 6.91 ± 2.20 | 7.35 (0.70–32.0) | 5.95 ± 2.22 | 6.40 (0.70–26.0) | 9.46 ± 1.99 | 10.0 (1.20–32.0) | |
| Hexachlorobenzene | 99 | 26.0 ± 1.87 | 27.0 (2.50–110) | 23.0 ± 1.84 | 24.0 (2.50–71.0) | 33.7 ± 1.81 | 32.0 (10.0–110) | |
| Mirex | 63.7 | 2.15 ± 2.45 | 2.50 (0.50–12.0) | 1.76 ± 2.34 | 2.00 (0.50–9.70) | 3.23 ± 2.37 | 3.00 (0.50–12.0) | |
| Oxychlordane | 98 | 15.6 ± 2.35 | 16.5 (1.00–77.0) | 13.0 ± 2.36 | 15.0 (1.00–77.0) | 22.7 ± 2.07 | 24.0 (4.40–76.0) | |
| p,p’-DDE | 99 | 108 ± 2.16 | 110 (5.00–530) | 93.6 ± 2.17 | 93.0 (5.00–350) | 144 ± 1.96 | 160 (31.0–530) | |
| ß-HCH | 86 | 3.29 ± 2.03 | 3.50 (0.50–16.0) | 3.02 ± 2.07 | 3.40 (0.50–9.40) | 3.96 ± 1.89 | 3.90 (0.50–16.0) | |
| trans-Nonachlor | 96 | 36.2 ± 2.29 | 39.5 (3.10–180) | 30.9 ± 2.31 | 35.0 (3.10–150) | 50.4 ± 2.04 | 49.0 (7.60–180) | |
| 209 ± 2.04 | 213 (17.6–939) | 182 ± 2.04 | 174 (17.6–637) | 278 ± 1.90 | 293 (64.6–939) | |||
| 371 ± 1.93 | 372 (55.3–1613) | 328 ± 1.92 | 322 (55.3–1216) | 482 ± 1.82 | 484 (149–1613) | |||
| 392 ± 1.85 | 389 (70.3–1642) | 345 ± 1.85 | 332 (70.3–1245) | 505 ± 1.78 | 488 (168–1642) | |||
| PFHxS | 99 | 0.39 ± 1.70 | 0.38 (0.04–1.07) | 0.36 ± 1.77 | 0.37 (0.04–1.07) | 0.44 ± 1.50 | 0.44 (0.19–0.88) | |
| PFHpS | 74 | 0.13 ± 1.85 | 0.14 (0.06–0.36) | 0.12 ± 1.88 | 0.14 (0.06–0.36) | 0.17 ± 1.62 | 0.17 (0.06–0.36) | |
| PFOS | 100 | 7.94 ± 1.64 | 8.44 (1.45–19.2) | 7.33 ± 1.65 | 7.64 (1.45–19.0) | 9.36 ± 1.57 | 10.3 (3.86–19.2) | |
| 9.39 ± 1.55 | 9.83 (2.40–21.1) | 8.76 ± 1.55 | 8.95 (2.40–20.8) | 10.9 ± 1.51 | 11.7 (5.04–21.1) | |||
| PFOA | 99 | 0.95 ± 1.88 | 0.99 (0.10–7.26) | 0.99 ± 1.93 | 0.99 (0.18–7.26) | 0.86 ± 1.77 | 0.98 (0.10–1.85) | 0.270 |
| PFNA | 100 | 1.07 ± 1.59 | 1.07 (0.21–3.26) | 0.99 ± 1.61 | 1.01 (0.21–3.26) | 1.25 ± 1.49 | 1.18 (0.59–2.87) | |
| PFDA | 100 | 0.71 ± 1.77 | 0.71 (0.14–2.32) | 0.67 ± 1.76 | 0.68 (0.14–2.32) | 0.83 ± 1.75 | 0.87 (0.20–2.08) | |
| PFUnA | 99 | 1.31 ± 2.38 | 1.47 (0.15–8.12) | 1.23 ± 2.32 | 1.38 (0.15–8.12) | 1.50 ± 2.51 | 1.79 (0.17–6.19) | 0.292 |
| 5.73 ± 1.64 | 5.53 (1.43–17.1) | 5.54 ± 1.67 | 5.41 (1.43–17.1) | 6.13 ± 1.58 | 5.59 (2.52–16.7) | 0.338 | ||
| ∑PFASs | 15.4 ± 1.54 | 15.6 (3.83–35.8) | 14.6 ± 1.55 | 15.2 (3.83–35.8) | 17.2 ± 1.49 | 17.6 (8.64–35.7) | ||
| Hg | 66 | 3.79 ± 2.17 | 4.06 (0.42–69.3) | 3.30 ± 1.82 | 3.47 (0.58–17.9) | 5.05 ± 2.71 | 5.25 (0.42–69.3) | |
| Pb | 98 | 7.27 ± 1.75 | 6.55 (1.58–64.1) | 7.03 ± 1.85 | 6.34 (1.58–64.1) | 7.80 ± 1.53 | 8.40 (3.15–27.3) | 0.381 |
| Cd | 43.1 | 0.58 ± 2.26 | 0.53 (0.11–3.15) | 0.52 ± 2.38 | 0.53 (0.11–3.15) | 0.73 ± 1.92 | 0.53 (0.21–3.15) | |
| Se | 100 | 141 ± 1.57 | 130 (65.4–1065) | 128 ± 1.37 | 117 (65.4–292) | 173 ± 1.83 | 156 (79.8–1065) | |
N number of participants, GM geometric mean, GSD geometric standard deviation, DL detection limit, p-Values was calculated with T-test on ln-transformed data. Bold text and * = Significant (p ≤ 0.050), Bold text and ** = Borderline significant (p ≤ 0.100).
Linear regression analysis of associations between prenatal OCP exposure and continuous SDQ score: Greenlandic children 3–5 years of age born 2014–2016 in the ACCEPT birth cohort.
| All (n = 95) | ||||||
|---|---|---|---|---|---|---|
| OCPs (µg/kg lipid) | Unadjusted | Adjustment model 1 | Adjustment model 2 | |||
| β (95% CI) | β (95% CI) | β (95% CI) | ||||
| Cont | 0.05 (− 0.11, 0.21) | 0.533 | 0.07 (− 0.10, 0.24) | 0.403 | 0.06 (− 0.11, 0.24) | 0.457 |
| Low | Ref | Ref | Ref | |||
| Med | 0.05 (− 2.45, 2.56) | 0.967 | 1.38 (− 1.01, 3.77) | 0.258 | 1.17 (− 1.29, 3.63) | 0.351 |
| High | 0.18 (− 2.75, 2.38) | 0.889 | 1.36 (− 1.13, 3.84) | 0.286 | 1.22 (− 1.32, 3.76) | 0.346 |
| p-trend | 0.892 | 0.795 | 0.938 | |||
| Cont | 0.02 (− 0.04, 0.07) | 0.543 | 0.02 (− 0.04, 0.07) | 0.566 | 0.01 (− 0.04, 0.07) | 0.641 |
| Low | Ref | Ref | Ref | |||
| Med | 1.91 (− 0.59, 4.40) | 0.134 | 3.06 (0.74, 5.39) | 2.95 (0.60, 5.30) | ||
| High | 0.31 (− 2.21, 2.82) | 0.812 | 1.71 (− 0.68, 4.10) | 0.161 | 1.59 (− 0.83, 4.01) | 0.197 |
| p-trend | 0.805 | 0.555 | 0.668 | |||
| Cont | − 0.11 (− 0.51, 0.29) | 0.572 | − 0.12 (− 0.53, 0.29) | 0.557 | − 0.14 (− 0.55, 0.27) | 0.503 |
| Low | Ref | Ref | Ref | |||
| Med | − 1.88 (− 4.34, 0.58) | 0.134 | − 0.66 (− 3.16, 1.85) | 0.608 | − 0.97 (− 3.55, 1.61) | 0.462 |
| High | − 1.14 (− 3.64, 1.37) | 0.374 | 0.17 (− 2.31, 2.65) | 0.892 | − 0.01 (− 2.49, 2.46) | 0.991 |
| p-trend | 0.351 | 0.444 | 0.385 | |||
| Cont | 0.03 (− 0.03, 0.09) | 0.404 | 0.03 (− 0.04, 0.09) | 0.415 | 0.02 (− 0.04, 0.08) | 0.475 |
| Low | Ref | Ref | Ref | |||
| Med | − 0.52 (− 3.00, 1.97) | 0.684 | 0.78 (− 1.64, 3.20) | 0.528 | 0.56 (− 1.89, 3.02) | 0.654 |
| High | 0.28 (− 2.28, 2.85) | 0.829 | 1.57 (− 0.88, 4.01) | 0.209 | 1.42 (− 1.07, 3.91) | 0.262 |
| p-trend | 0.849 | 0.630 | 0.757 | |||
| Cont | 0.01 (− 0.01, 0.02) | 0.330 | 0.01 (− 0.01, 0.02) | 0.322 | 0.01 (− 0.01, 0.02) | 0.368 |
| Low | Ref | Ref | Ref | |||
| Med | − 0.06 (− 2.55, 2.43) | 0.962 | 0.42 (− 2.03, 2.86) | 0.738 | 0.22 (− 2.29, 2.72) | 0.866 |
| High | 0.66 (− 1.95, 3.26) | 0.621 | 1.93 (− 0.58, 4.45) | 0.132 | 1.74 (− 0.81, 4.28) | 0.180 |
| p-trend | 0.631 | 0.422 | 0.519 | |||
| Cont | 0.18 (− 0.22, 0.58) | 0.371 | 0.26 (− 0.17, 0.68) | 0.231 | 0.24 (− 0.19, 0.67) | 0.264 |
| Low | Ref | Ref | Ref | |||
| Med | 2.20 (− 0.29, 4.68) | 3.58 (1.16, 6.00) | 3.51 (1.04, 5.98) | |||
| High | 0.48 (− 2.04, 3.01) | 0.707 | 2.03 (− 0.39, 4.45) | 1.95 (− 0.53, 4.43) | 0.123 | |
| p-trend | 0.715 | 0.419 | 0.523 | |||
| Cont | 0.01 (− 0.02, 0.04) | 0.418 | 0.02 (− 0.01, 0.04) | 0.319 | 0.01 (− 0.02, 0.04) | 0.366 |
| Low | Ref | Ref | Ref | |||
| Med | 0.68 (− 1.79, 3.14) | 0.590 | 2.06 (− 0.26, 4.39) | 1.90 (− 0.48, 4.27) | 0.117 | |
| High | − 0.11 (− 2.70, 2.48) | 0.935 | 1.61 (− 0.91, 4.14) | 0.210 | 1.52 (− 1.01, 4.09) | 0.249 |
| p-trend | 0.962 | 0.660 | 0.788 | |||
| Cont | 0.00 (− 0.00, 0.01) | 0.377 | 0.00 (− 0.00, 0.01) | 0.349 | 0.00 (− 0.00, 0.01) | 0.400 |
| Low | Ref | Ref | Ref | |||
| Med | 0.97 (− 1.51, 3.45) | 0.443 | 1.97 (− 0.46, 4.41) | 0.113 | 1.83 (− 0.65, 4.31) | 0.149 |
| High | 0.18 (− 2.38, 2.74) | 0.889 | 1.36 (− 1.06, 3.78) | 0.270 | 1.22 (− 1.26, 3.69) | 0.335 |
| p-trend | 0.868 | 0.650 | 0.780 | |||
n Number of participants in parameter, β Linear regression coefficient in score points, CI confidence interval, Bold text and * = Significant (p ≤ 0.050), Bold text and ** = Borderline significant (p ≤ 0.100), Adjustment model 1: Maternal plasma cotinine, maternal educational level, maternal age at delivery, Adjustment model 2: Adjustment model 1 + breast-feeding duration, Med = Medium, Cont. = Continuous, OCPs organochlorine pesticides.
Linear regression analysis of the associations between prenatal OCP exposure and continuous hyperactivity score: Greenlandic children 3–5 years of age born 2014–2016, the ACCEPT birth cohort.
| All (n = 101) | ||||||
|---|---|---|---|---|---|---|
| OCPs (µg/kg lipid) | Unadjusted | Adjustment model 1 | Adjustment model 2 | |||
| β (95% CI) | β (95% CI) | β (95% CI) | ||||
| Cont | 0.03 (− 0.03, 0.09) | 0.279 | 0.03 (− 0.03, 0.09) | 0.311 | 0.03 (− 0.03, 0.10) | 0.278 |
| Low | Ref | Ref | Ref | |||
| Med | − 0.49 (− 1.38, 0.41) | 0.287 | − 0.44 (− 1.33, 0.46) | 0.341 | − 0.40 (− 1.33, 0.53) | 0.398 |
| High | 0.01 (– 0.88, 0.91) | 0.975 | 0.19 (– 0.73, 1.10) | 0.686 | 0.22 (– 0.72, 1.15) | 0.651 |
| p-trend | 0.967 | 0.967 | 0.884 | |||
| Cont | 0.00 (− 0.02, 0.02) | 0.797 | 0.00 (− 0.02, 0.02) | 0.873 | 0.00 (− 0.02, 0.02) | 0.814 |
| Low | Ref | Ref | Ref | |||
| Med | − 0.20 (− 1.09, 0.70) | 0.665 | − 0.24 (− 1.13, 0.65) | 0.603 | − 0.22 (− 1.13, 0.68) | 0.627 |
| High | − 0.09 (− 1.00, 0.82) | 0.844 | 0.08 (− 0.85, 1.00) | 0.874 | 0.09 (− 0.85, 1.04) | 0.848 |
| p-trend | 0.846 | 0.822 | 0.887 | |||
| Cont | − 0.01 (− 0.15, 0.13) | 0.882 | − 0.02 (− 0.17, 0.13) | 0.807 | − 0.02 (− 0.16, 0.13) | 0.843 |
| Low | Ref | Ref | Ref | |||
| Med | − 1.01 (− 1.87, − 0.14) | − 1.18 (− 2.08, − 0.28) | − 1.35 (− 2.23, − 0.43) | |||
| High | − 0.26 (− 1.12, 0.61) | 0.561 | − 0.14 (− 1.02, 0.75) | 0.766 | − 0.23 (− 1.12, 0.66) | 0.616 |
| p-trend | 0.517 | 0.447 | 0.467 | |||
| Cont | 0.01 (− 0.01, 0.03) | 0.234 | 0.01 (− 0.01, 0.04) | 0.271 | 0.01 (− 0.01, 0.04) | 0.246 |
| Low | Ref | Ref | Ref | |||
| Med | − 0.56 (− 1.44, 0.32) | 0.215 | − 0.71, (− 1.60, 0.19) | 0.121 | − 0.71 (− 1.62, 0.21) | 0.129 |
| High | 0.14 (− 0.75, 1.03) | 0.764 | 0.23 (− 0.66, 1.11) | 0.617 | 0.25 (− 0.65, 1.16) | 0.585 |
| p-trend | 0.910 | 0.973 | 0.946 | |||
| Cont | 0.00 (− 0.00, 0.01) | 0.237 | 0.00 (− 0.00. 0.01) | 0.284 | 0.00 (− 0.00, 0.01) | 0.256 |
| Low | Ref | Ref | Ref | |||
| Med | − 0.32 (− 1.20, 0.56) | 0.476 | − 0.59 (− 1.50, 0.32) | 0.205 | − 0.59 (− 1.53, 0.35) | 0.217 |
| High | 0.06 (− 0.86, 0.98) | 0.895 | 0.10 (− 0.83, 1.04) | 0.830 | 0.13 (− 0.82, 1.08) | 0.788 |
| p-trend | 0.780 | 0.853 | 0.776 | |||
| Cont | 0.08 (− 0.06, 0.22) | 0.269 | 0.08 (− 0.07, 0.23) | 0.294 | 0.09 (− 0.07, 0.25) | 0.260 |
| Low | Ref | Ref | Ref | |||
| Med | 0.50 (− 0.39, 1.39) | 0.270 | 0.55 (− 0.37, 1.48) | 0.240 | 0.65 (− 0.29, 1.82) | 0.177 |
| High | 0.22 (− 0.68, 1.11) | 0.637 | 0.46 (− 0.48, 1.39) | 0.337 | 0.53 (− 0.43, 1.49) | 0.278 |
| p-trend | 0.637 | 0.650 | 0.566 | |||
| Cont | 0.01 (− 0.00, 0.02) | 0.208 | 0.01 (− 0.00, 0.02) | 0.231 | 0.01 (− 0.00, 0.02) | 0.209 |
| Low | Ref | Ref | Ref | |||
| Med | − 0.50 (− 1.38, 0.38) | 0.265 | − 0.48 (− 1.35, 0.40) | 0.285 | − 0.44 (− 1.34, 0.45) | 0.334 |
| High | 0.19 (− 0.71, 1.08) | 0.685 | 0.35 (− 0.58, 1.28) | 0.458 | 0.39 (− 0.55, 1.34) | 0.416 |
| p-trend | 0.712 | 0.725 | 0.649 | |||
| Cont | 0.00 (− 0.00, 0.00) | 0.265 | 0.00 (− 0.00, 0.00) | 0.309 | 0.00 (− 0.00, 0.00) | 0.278 |
| Low | Ref | Ref | Ref | |||
| Med | − 0.32 (− 1.21, 0.56) | 0.473 | − 0.56 (− 1.47, 0.34) | 0.223 | − 0.52 (− 1.45, 0.41) | 0.271 |
| High | 0.34 (− 0.55, 1.24) | 0.449 | 0.37 (− 0.52, 1.26) | 0.415 | 0.40 (− 0.51, 1.31) | 0.391 |
| p-trend | 0.466 | 0.526 | 0.457 | |||
n Number of participants in parameter, β Linear regression coefficient in score points, CI confidence interval, Bold text and *= Significant (p ≤ 0.050), Bold text and ** = Borderline significant (p ≤ 0.100), Adjustment model 1: Maternal plasma cotinine, maternal educational level, maternal age at delivery, Adjustment model 2: Adjustment model 1 + breast-feeding duration, Med = Medium, Cont. = Continuous, OCPs organochlorine pesticides.
Logistic regression analysis of associations between continuous prenatal OCP exposure and abnormal SDQ score: Greenlandic children 3–5 years of age born 2014–2016, the ACCEPT birth cohort.
| Unadjusted | Adjustment model 1 | Adjustment model 2 | ||||
|---|---|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | OR (95% CI) | ||||
| cis-Nonachlor | 1.08 (1.00, 1.18) | 1.09 (0.99, 1.20) | 1.09 (0.99, 1.20) | |||
| Hexachlorobenzene | 1.02 (1.00, 1.05) | 1.02 (0.99, 1.05) | 0.237 | 1.02 (0.99, 1.05) | 0.295 | |
| Mirex | 1.13 (0.92, 1.39) | 0.258 | 1.08 (0.86, 1.36) | 0.488 | 1.07 (0.85, 1.35) | 0.553 |
| Oxychlordane | 1.02 (0.99, 1.06) | 0.106 | 1.02 (0.99, 1.05) | 0.216 | 1.02 (0.99, 1.05) | 0.264 |
| p,p’-DDE | 1.01 (1.00, 1.01) | 1.01 (1.00, 1.01) | 1.01 (1.00, 1.01) | |||
| ß-HCH | 1.15 (0.95, 1.40) | 0.150 | 1.15 (0.91, 1.44) | 0.248 | 1.13 (0.89,1.44) | 0.301 |
| trans-Nonachlor | 1.01 (1.00, 1.03) | 1.01 (1.00, 1.03) | 1.01 (1.00, 1.03) | 0.113 | ||
| 1.00 (1.00, 1.01) | 1.00 (1.00, 1.01) | 1.00 (1.00, 1.01) | 0.114 | |||
Normal/borderline n = 84, Abnormal n = 11, OR odds-ratio, CI confidence interval, Bold text and * = Significant (p ≤ 0.050), Bold text and ** = Borderline significant (p ≤ 0.100), Adjustment model 1: Maternal plasma cotinine, maternal educational level, maternal age at delivery, Adjustment model 2: Adjustment model 1 + breast-feeding duration, OCPs Organochlorine pesticides.
Logistic regression analysis of associations between prenatal OCP exposure and abnormal hyperactivity score: Greenlandic children 3–5 years of age born 2014–2016, the ACCEPT birth cohort.
| Unadjusted | Adjustment model 1 | Adjustment model 2 | ||||
|---|---|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | OR (95% CI) | ||||
| cis-Nonachlor | 1.07 (0.96, 1.20) | 0.240 | 1.10 (0.97, 1.24) | 0.148 | 1.09 (0.97, 1.24) | 0.151 |
| Hexachlorobenzene | 1.02 (0.98, 1.05) | 0.417 | 1.02 (0.98, 1.06) | 0.276 | 1.02 (0.98, 1.06) | 0.289 |
| Mirex | 1.21 (0.93, 1.58) | 0.164 | 1.28 (0.96, 1.72) | 1.28 (0.96, 1.72) | ||
| Oxychlordane | 1.03 (0.99, 1.07) | 0.105 | 1.04 (1.00, 1.08) | 1.04 (1.00, 1.08) | ||
| p,p’-DDE | 1.00 (1.00, 1.01) | 0.469 | 1.00 (1.00, 1.01) | 0.342 | 1.00 (1.00, 1.01) | 0.351 |
| ß-HCH | 1.12 (0.86, 1.46) | 0.400 | 1.20 (0.88, 1.64) | 0.245 | 1.19 (0.88, 1.61) | 0.254 |
| trans-Nonachlor | 1.02 (1.00, 1.03) | 0.118 | 1.02 (1.00, 1.04) | 1.02 (1.00, 1.04) | ||
| 1.00 (1.00, 1.01) | 0.290 | 1.00 (1.00, 1.01) | 0.189 | 1.00 (1.00, 1.01) | 0.200 | |
Normal/borderline n = 96, Abnormal n = 5, OR odds-ratio, CI confidence interval, Bold text and * = Significant (p ≤ 0.050), Bold text and ** = Borderline significant (p ≤ 0.100), Adjustment model 1: Maternal plasma cotinine, maternal educational level, maternal age at delivery, Adjustment model 2: Adjustment model 1 + breast-feeding duration, OCPs organochlorine pesticides.